When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Results from a 28-week open-label study, MAPLE, evaluating Allergan (NYSE:AGN) and licensor Molecular Partners' (OTCPK:MLLCF) abicipar in 123 patients with age-related neovascular macular degeneration (nAMD) showed an improved safety profile after the manufacturing process was modified.
More news on: Allergan plc, Molecular Partners AG, Healthcare stocks news,